CCCC 8-K 2026-06-24

C4 Therapeutics, Inc. (CCCC) 8-K dated 2026-06-24 — accession 0001628280-26-045194. This URL is the filing, not the CCCC hub.

C4 Therapeutics, Inc. (CCCC) is a biotechnology company listed on US.

C4 Therapeutics, Inc. filed a 8-K on 2026-06-24. Accession 0001628280-26-045194.

Cached items: 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CCCC revenue for 2026-06-30 was $12.8M. Net income was -$48.8M. CCCC currently screens at market cap $425.7M.

Not investment advice. The CCCC SEC hub lists recent forms. The stock page is the research view.